Market closed

Pulse Biosciences/$PLSE

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Pulse Biosciences

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Ticker

$PLSE
Trading on

Industry

Health Care Equipment & Supplies

Employees

56

PLSE Metrics

BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$0.83
EPS
1.74
Beta
-
Dividend rate
$1.1B
1.74
$22.69
$4.57
133K
11.929
11.724
9.066
10.574
-44.12%
-38.15%
-70.28%
14.03
14.81
-29.354
-5.61%
-28.80%

What the Analysts think about PLSE

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Pulse Biosciences stock.

PLSE Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

PLSE Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PLSE

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Pulse Biosciences stock?

Pulse Biosciences (PLSE) has a market cap of $1.1B as of November 08, 2024.

What is the P/E ratio for Pulse Biosciences stock?

The price to earnings (P/E) ratio for Pulse Biosciences (PLSE) stock is 0 as of November 08, 2024.

Does Pulse Biosciences stock pay dividends?

No, Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders as of November 08, 2024.

When is the next Pulse Biosciences dividend payment date?

Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders.

What is the beta indicator for Pulse Biosciences?

Pulse Biosciences (PLSE) has a beta rating of 1.74. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.